Skip to content

Comparative study to find the effect of lajjalu powder and indrayava powder in management of menorrhagia with special reference to modern aspect

Comparative clinical trial to determine the effect of lajjalu churna and indrayava churna in management of raktapradara W.S.R.to menorrhagia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091599
Enrollment
80
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E289- Ovarian dysfunction, unspecified

Interventions

None listed

Sponsors

Gulnaj Sherkhan Pathan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients who will give informed written consent for study 2 patients having sign and symptoms of Raktapradara such as Raja ati pravrutti,Dirgha kala artava pravrutti,Vedna in shroni prushtha and Kukshi,Yonigat daha,Daurbalya,Angmard and Hemoglobin above 7gm/dl

Exclusion criteria

Exclusion criteria: 1 k/c/o pelvic and uterine pathology like Uterine fibroid,Polyp, Pelvic inflammatory disease, Adenomyosis, Post menopausal bleeding, malignant and non malignant tumors 2 k/c/o Any significant chronic illness 3 k/c/o ectopic pregnancy, abortion 4 k/c/o Any external injury to reproductive track 5 patients with IUCD and on OCP pills 6 Patient taking Anti coagulation therapy and having any coagulant defects like Thrombocytopenic Purpura

Design outcomes

Primary

MeasureTime frame
Improvement in MenorrhagiaTimepoint: 12 weeks

Secondary

MeasureTime frame
Decrease in amount & duration of menstrual bleedingTimepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Sonal Wagh

SST Ayurved Mahavidyalaya, Sangamner

sonaldere1@gmail.com9960212188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026